US FDA declines to approve Corcept’s drug for rare hormonal disorder
By Sneha S K and Sahil Pandey Dec 31 (Reuters) – The U.S. Food and Drug Administration has…
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
Vanda Jumps 21% After FDA Approves Motion Sickness Therapy
This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
Inside the FDA’s vaccine uproar
Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused…
FDA OKs libido-boosting pill for older women who have gone through menopause
WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late…
Appointment of controversial FDA official rocking agency like “an atom bomb,” scientists there say
The Trump administration’s elevation of a vaccine skeptic to lead a high-profile office within the Food and Drug…
Blood pressure drug recalled for possible cross-contamination
Thousands of bottles of a commonly used prescription drug to treat hypertension has been recalled for possible contamination…
Top FDA drug regulator plans to depart weeks into job
The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal
Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…